230 related articles for article (PubMed ID: 11725344)
1. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis.
Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
Int J Hyg Environ Health; 2001 Oct; 204(1):43-7. PubMed ID: 11725344
[TBL] [Abstract][Full Text] [Related]
2. [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].
Lando C; Hagmar L; Bonassi S
Med Lav; 1998; 89(2):124-31. PubMed ID: 9673102
[TBL] [Abstract][Full Text] [Related]
3. A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage.
Mutat Res; 1990 Jul; 241(3):325-37. PubMed ID: 2366811
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
[TBL] [Abstract][Full Text] [Related]
5. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes.
Bolognesi C; Abbondandolo A; Barale R; Casalone R; Dalprà L; De Ferrari M; Degrassi F; Forni A; Lamberti L; Lando C; Migliore L; Padovani P; Pasquini R; Puntoni R; Sbrana I; Stella M; Bonassi S
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):249-56. PubMed ID: 9107430
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations.
Tuimala J; Szekely G; Wikman H; Järventaus H; Hirvonen A; Gundy S; Norppa H
Mutat Res; 2004 Oct; 554(1-2):319-33. PubMed ID: 15450429
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of intermediate endpoints in environmental and occupational health.
Knudsen LE; Hansen AM
Int J Hyg Environ Health; 2007 May; 210(3-4):461-70. PubMed ID: 17321211
[TBL] [Abstract][Full Text] [Related]
9. The genotoxic risk of underground coal miners from Turkey.
Donbak L; Rencuzogullari E; Yavuz A; Topaktas M
Mutat Res; 2005 Dec; 588(2):82-7. PubMed ID: 16337427
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal, India.
Mahata J; Chaki M; Ghosh P; Das LK; Baidya K; Ray K; Natarajan AT; Giri AK
Cytogenet Genome Res; 2004; 104(1-4):359-64. PubMed ID: 15162065
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic biomonitoring study of population residing in pesticide contaminated regions in Göksu Delta: micronucleus, chromosomal aberrations and sister chromatid exchanges.
Ergene S; Celik A; Cavaş T; Kaya F
Environ Int; 2007 Oct; 33(7):877-85. PubMed ID: 17493680
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic damage in pathology anatomy laboratory workers exposed to formaldehyde.
Costa S; Coelho P; Costa C; Silva S; Mayan O; Santos LS; Gaspar J; Teixeira JP
Toxicology; 2008 Oct; 252(1-3):40-8. PubMed ID: 18721846
[TBL] [Abstract][Full Text] [Related]
13. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.
Hagmar L; Bonassi S; Strömberg U; Mikoczy Z; Lando C; Hansteen IL; Montagud AH; Knudsen L; Norppa H; Reuterwall C; Tinnerberg H; Brogger A; Forni A; Högstedt B; Lambert B; Mitelman F; Nordenson I; Salomaa S; Skerfving S
Mutat Res; 1998 Sep; 405(2):171-8. PubMed ID: 9748557
[TBL] [Abstract][Full Text] [Related]
14. [Sister chromatid exchange (SCE)and high-frequency cells in workers professionally exposed to extremely low-frequency magnetic fields (ELF)].
Gobba F; Roccatto L; Sinigaglia B; Temperani P
Med Lav; 2003; 94(5):450-8. PubMed ID: 14619183
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of sister chromatid exchange and micronuclei as biological endpoints.
Sorsa M
IARC Sci Publ; 1984; (59):339-49. PubMed ID: 6545285
[TBL] [Abstract][Full Text] [Related]
16. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.
Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
IARC Sci Publ; 2004; (157):207-15. PubMed ID: 15055297
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity of cadmium chloride in human lymphocytes evaluated by the comet assay and cytogenetic tests.
Rozgaj R; Kasuba V; Fucić A
J Trace Elem Med Biol; 2002; 16(3):187-92. PubMed ID: 12437157
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic biomarkers.
Norppa H
IARC Sci Publ; 2004; (157):179-205. PubMed ID: 15055296
[TBL] [Abstract][Full Text] [Related]
20. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
